- 1 MERCK: FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib
- 2 State institution: These 4-year New Jersey schools attract the fewest in-state students
- 3 KONICA MINOLTA BUSINESS SOLUTIONS U.S.A, INC: Konica Minolta Supports the National Kidney Foundation in the Fight Against Kidney Disease
- 4 CELGENE CORPORATION: New Survey Reveals Myelodysplastic Syndromes Leave Patients Feeling Fatigued
- 5 CELGENE CORPORATION: Celgene Named Among World’s Best Employers 2018
Get the latest business news and updates - delivered right to your inbox
By signing up you agree to receive email newsletters or alerts from New Jersey Business Daily. You can unsubscribe at any time.